What is recommended and what remains open in the American Heart Association recommendations for the standardization and interpretation of the electrocardiogram. Part V: electrocardiogram changes associated with cardiac chamber hypertrophy

Journal of Electrocardiology

Volumn 42, Issue 5, 2009, Pages 388-391

  Bacharova, Ljuba ^a  

^a INTERNATIONAL LASER CENTER   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; HEART ATRIUM CONDUCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART REPOLARIZATION; HUMAN; MEDICAL SOCIETY; P WAVE; PRIORITY JOURNAL; QRS COMPLEX; ST SEGMENT; STANDARDIZATION; T WAVE;

CARDIOLOGY; ELECTROCARDIOGRAPHY; GUIDELINE ADHERENCE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 68849114889     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2009.07.002     Document Type: Editorial

References (24)

1. Gettes L.S. The status of the standards. J Electrocardiol 42 (2009) 213
2. Hancock E.W., Deal B.J., Mirvis D.M., et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 53 (2009) 992
3. Okin P.M., Devereux R.B., Jern S., Kjeldsen S.E., Julius S., and Dahlöf B. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension 36 (2000) 766
4. Okin P.M., Devereux R.B., Jern S., et al., for the LIFE STUDY Investigators. Regression of electrocardiographic let ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 292 (2004) 2343
5. Li Z.B., Wachtell K., Okin P.M., et al. Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hum Hypertens 18 (2004) 397
6. Okin P.M., Wachtell K., Devereux R.B., et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA 296 (2006) 1242
7. Okin P.M., Devereux R.B., Harris K.E., et al. Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients. Ann Intern Med 147 (2007) 311
8. Romhilt D.W., and Estes Jr. E.H. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 75 (1968) 752
9. Bacharova L. The "high voltage trap" in the electrocardiographic diagnosis of left ventricular hypertrophy. J Electrocardiol 41 (2008) 351
10. Bayley R.H. Biophysical principles of electrocardiography (1958), Paul B. Hoeber Inc, New York
11. Scher A.M. Trends in electrocardiographic recording. In: Schlant R.C., and Hurst J.W. (Eds). Advances in electrocardiography (1972), Grune & Stratton, New York 1
12. Kleber A.G., and Rudy J. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 84 (2004) 431
13. Bacharova L. Electrical and structural remodeling in left ventricular hypertrophy-a substrate for a decrease in QRS voltage?. ANE 12 (2007) 260
14. Wasson S., Reddy H.K., and Dohrmann M.L. Current perspectives of electrical remodeling and its therapeutic implications. J Cardiovasc Pharmacol Ther 9 (2004) 129
15. Bacharova L., and Estes E.H. Electrocardiographic diagnosis of left ventricular hypertrophy: depolarization changes. J Electrocardiol 42 (2009) 228
16. Danik S.B., Liu F., Zhang J., et al. Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res 95 (2004) 1035
17. Morley G.E., Danik S., Bernstein, Sun Y., Rosner G., and Gutstein D.E. Reduced intercellular coupling leads to paradoxical propagation across the Purkinje-ventricular junction and aberrant myocardial activation. PNAS 102 (2005) 4126
18. Bacharova L., Plandorova J., Klimas J., Krenek P., and Kyselovic J. Discrepancy between increased left ventricular mass and "normal" QRS voltage is associated with decreased connexin43 expression in early stage of left ventricular hypertrophy in spontaneously hypertensive rats. J Electrocardiol 41 (2008) 730
19. Bacharova L, Szathmary V, Kovalcik M, Mateasik A. Effect of changes in left ventricular anatomy and conduction velocity on the QRS voltage and morphology in left ventricular hypertrophy: a model study. J Electrocardiol [accepted for publication].
20. Kurisu S., Inoue I., Kawagoe T., et al. The decrease in QRS amplitude after aortic valve replacement in patients with aortic valve stenosis. J Electrocardiol 42 (2009) 410
21. Michaelides A.P., Liakos C.I., Raftopoulos L.G., et al. Electrocardiographic criteria for detecting coronary artery disease in hypertensive patients with ST-segment changes during exercise testing. J Electrocardiol 42 (2009) 405
22. Rekik S., Aboukhoudir F., Andrieu S., Pansieri M., and Hirsch J.L. Impressive ST-segment elevation during dobutamine stress echocardiography in a patient with normal coronary arteries: dobutamine-induced vasospasm?. J Electrocardiol 42 (2009) 414
23. Milewska A., Guzik P., Rudzka M., et al. J-wave formation in patients with acute intracranial hypertension. J Electrocardiol 42 (2009) 420
24. Görenek B., and Kudaiberdieva G. Letter to the Editor. J Electrocardiol 42 (2009) 424